Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03013218
Title A Study of ALX148 in Patients With Advanced Solid Tumors and Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Alexo Therapeutics, Inc.
Indications

Advanced Solid Tumor

lymphoma

Therapies

Evorpacept

Atezolizumab + Evorpacept

Evorpacept + Trastuzumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.